MEK1/2和ERK1/2介导的肺内皮损伤及止血异常促进小鼠狼疮弥漫性肺泡出血
研究在降植烷诱导的狼疮小鼠模型中比较B6与BALB/c小鼠对弥漫性肺泡出血(DAH)的易感性,发现MEK1/2抑制剂曲美替尼(GSK1120212)和ERK1/2抑制剂SCH772984可消除DAH,而JNK和p38抑制剂无效;MEK1/2-ERK1/2通路激活导致肺内皮损伤和止血异常,遗传因素决定肺损伤和出血易感性,可能与系统性红斑狼疮中危及生命的DAH病理生理相关并可能有助于优化治疗。
要点
- MEK1/2抑制剂GSK1120212和ERK1/2抑制剂SCH772984可消除降植烷诱导B6小鼠的DAH,JNK和p38抑制剂无效。
- 降植烷处理B6小鼠肺组织出现凋亡细胞和内皮功能障碍,GSK治疗组无凋亡细胞且内皮功能障碍恢复正常。
- 降植烷增加B6小鼠抗凝血基因Tfpi和Thbd表达及循环血栓调节蛋白水平,GSK可使其恢复正常。
核心结论
- 降植烷处理通过激活MEK1/2-ERK1/2通路并损害止血,促进B6小鼠肺内皮损伤和DAH。
- 决定降植烷诱导狼疮肺损伤和出血易感性的遗传因素与系统性红斑狼疮中危及生命的DAH病理生理相关,并可能有助于优化治疗。
研究设计与样本
- 研究使用降植烷处理的B6和BALB/c小鼠,分别给予或不给予MEK1/2抑制剂曲美替尼(GSK1120212,GSK)、ERK1/2抑制剂SCH772984(SCH)、JNK抑制剂或p38抑制剂,检测对肺出血和止血的影响。
主要发现
- GSK和SCH消除DAH,而JNK和p38抑制剂无效。
- 降植烷处理小鼠肺样本存在凋亡细胞,而降植烷加GSK组无凋亡细胞,且内皮功能障碍恢复正常。
- ERK1/2调节的转录因子早期生长反应因子1在降植烷处理的B6小鼠中表达增加,但在BALB/c小鼠中不增加,GSK使其表达恢复正常。
- 降植烷增加B6小鼠抗凝血基因Tfpi和Thbd表达,Tfpi与组织因子(F3)比值在B6小鼠中升高(BALB/c小鼠不升高),GSK使其恢复正常;循环血栓调节蛋白蛋白水平在B6小鼠中升高,GSK治疗后恢复正常。
- 与内皮抗凝血活性增强一致,降植烷处理增加B6小鼠尾部出血。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: About 3% of patients with lupus develop severe diffuse alveolar hemorrhage (DAH) with pulmonary vasculitis. C57BL/6 (B6) mice with pristane-induced lupus also develop DAH, but BALB/c mice are resistant. DAH is independent of Toll-like receptor signaling and other inflammatory pathways. This study examined the role of the MEK1/2 pathway (MEK1/2-ERK1/2, JNK, p38). METHODS: B6 and BALB/c mice were treated with pristane with or without inhibitors of MEK1/2 (trametinib/GSK1120212 [GSK]), ERK1/2 (SCH772984 [SCH]), JNK, or p38. Effects on lung hemorrhage and hemostasis were determined. RESULTS: GSK and SCH abolished DAH, whereas JNK and p38 inhibitors were ineffective. Apoptotic cells were present in lung samples from pristane-treated mice but not in mice receiving pristane and GSK, and endothelial dysfunction was normalized. Expression of the ERK1/2-regulated transcription factor early growth response 1 increased in pristane-treated B6, but not BALB/c, mice and was normalized by GSK. Pristane also increased expression of the anticoagulant genes Tfpi and Thbd in B6 mice. The ratio of Tfpi to tissue factor (F3) to Tfpi increased in B6 (but not BALB/c) mice and was normalized by GSK. Circulating thrombomodulin protein levels increased in B6 mice and returned to normal after GSK treatment. Consistent with augmented endothelial anticoagulant activity, pristane treatment increased tail bleeding in B6 mice. CONCLUSION: Pristane treatment promotes lung endothelial injury and DAH in B6 mice by activating the MEK1/2-ERK1/2 pathway and impairing hemostasis. The hereditary factors determining susceptibility to lung injury and bleeding in pristane-induced lupus are relevant to the pathophysiology of life-threatening DAH in systemic lupus erythematosus and may help to optimize therapy.
引用
- Zhuang H, Han S, Harris NS, et al. MEK1/2- and ERK1/2-Mediated Lung Endothelial Injury and Altered Hemostasis Promote Diffuse Alveolar Hemorrhage in Murine Lupus. Arthritis Rheumatol. 2024. PMID: 38923837. doi:10.1002/art.42936
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。